Taking early, decisive action is critical to help improve outcomes for these ... Vanrafia was seen in an additional group of patients treated with both a RAS inhibitor and an SGLT2 inhibitor (37.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback